Discovery could help stop malaria at its source -- the mosquitoAugust 30, 2007Troy, N.Y. - As summer temperatures cool in the United States, fewer mosquitoes whir around our tiki torches. But mosquitoes swarming around nearly 40 percent of the world's population will continue to spread a deadly parasitic disease - malaria. Now an interdisciplinary team led by researchers from Rensselaer Polytechnic Institute has found a key link that causes malarial infection in both humans and mosquitoes. If this link in the chain of infection can be broken at its source - the mosquito - then the spread of malaria could be stopped without any man, woman, or child needing to a take a drug. The researchers' discovery will be published in the Aug. 31 edition of the Journal of Biological Chemistry. The team found that humans and the mosquitoes that carry the malaria parasite share the same complex carbohydrate, heparan sulfate. In both humans and mosquitoes, heparan sulfate is a receptor for the malaria parasite, binding to the parasite and giving it quick and easy transport through the body. The team was led by Robert J. Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer.
"The discovery allows us to think differently about preventing the disease," Linhardt said. "If we can stop heparan sulfate from binding to the parasite in mosquitoes, we will not just be treating the disease, we will be stopping its spread completely." Malaria parasites are extremely finicky about their hosts, Linhardt explained. Birds, rodents, humans, and primates all can be infected with malaria, but each species is infected by a different species of mosquito - and each of those mosquitoes is infected by a different malaria parasite. In other words, there needs to be a perfect match at the molecular basis for malaria to spread from one species to another, Linhardt said. Researchers have long understood this deadly partnership, but the molecular basis for the match had never been determined. "The discovery marks a paradigm shift in stopping malaria," Linhardt said "Now, we can work to develop an environmentally safe, inexpensive way to block infection in mosquitoes and not have to worry about drug side effects in humans." Malaria kills over one million people around the world, mostly young children. And the problem is growing, Linhardt noted. As the Earth heats up due to global warming, outbreaks of malaria are being reported higher up the coast of South America and Mexico each year, he said. "Unfortunately, there is little direct funding on malaria in this country outside of the Bill and Melinda Gates Foundation, because it is not considered a major threat in this country," Linhardt noted. "We do our research on a shoestring. Malaria research funding needs to move higher up on the scientific priority list." Linhardt and his collaborators were the first to discover the link between the spread of malaria in humans and heparan sulfate in 2003. Those findings were also published in the Journal of Biological Chemistry. In this earlier study, Linhardt compared the receptors in the liver of humans to those of rodents. The liver is the first organ to be infected by the malaria parasite in mammals. The researchers found that heparan sulfate in the human liver was the unwitting transporter of the disease to the human bloodstream. The receptor found in rodents was a different heparan sulfate. The next step for Linhardt, outlined in the current research, was to determine if heparan sulfate was also present in the species of mosquito known to spread malaria to humans, Anopheles stephensi. To make this key link, Linhardt and his current research team, which includes Rensselaer doctoral students Melissa Kemp and Jin Xie, enlisted the help of New York University physician and entomologist Photini Sinnis. Sinnis and her team at NYU provided their entomological expertise and the ill-fated mosquitoes needed for the experiments. After finding heparan sulfate in mashed mosquitoes, the researchers needed to determine if heparan sulfate was in the mosquito organs known to host the malaria parasite. If so, it was likely that heparan sulfate was the reason malaria spreads from mosquito to human and human to mosquito. In mosquitoes, the malaria parasite infects the digestive tract. A mosquito bites a human who carries the malaria parasite in his or her bloodstream. The parasites move into the bug's gut and then to their salivary glands, allowing the mosquito to infect another human during its next blood meal. To isolate a two-microgram salivary gland and the four-microgram digestive tract from each mosquito required the extreme skill of Sinnis and her team, which included Alida Coppi. Once isolated, the guts and glands were analyzed by internationally renowned microanalysts Toshihiko Toida, Hidenao Toyoda, and Akiko Kinoshita-Toyoda at Chiba University in Japan. Heparan sulfate was found in both mosquito organs. As a final step, the Rensselaer team proved that the heparan sulfate in the mosquito bound to the same malaria parasite that heparan sulfate found in the human liver did. It was an unfortunate perfect match. Rensselaer Polytechnic Institute | |||||||||||||||||||||
|
Related Malaria Current Events and Malaria News Articles Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Applying 'supply and demand' business principles to treat infectious diseases worldwide Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. 'Airport malaria' -- cause for concern in the US In a global world, significant factors affect the spread of infectious diseases, including international trade, air travel and globalized food production. "Airport malaria" is a term coined by researchers to explain the more recent spread of malaria to areas such as the United States and Europe, which some scientists credit to warmer climate changes. Dramatic fall in malaria in the Gambia raises possibility of elimination in parts of Africa The incidence of malaria has fallen significantly in The Gambia in the last 5 years, according to a study carried out by experts there with support from scientists based in London. Researchers characterize potential protein targets for malaria vaccine Researchers from Nijmegen and Leiden have now characterized a large number of parasite proteins that may prove useful in the development of a human malaria vaccine. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows. Neighborhood greenness has long term positive impact on kids' health In the first study to look at the effect of neighborhood greenness on inner city children's weight over time, researchers from the Indiana University School of Medicine, Indiana University-Purdue University Indianapolis and the University of Washington report that higher neighborhood greenness is associated with slower increases in children's body mass over a two year period, regardless of residential density. Childhood environmental health Children are exposed to a wide range of environmental threats that can affect their health and development early in life, throughout their youth and into adulthood. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/). Governments urged to fight global child killer Pneumococcal disease, one of the world's leading causes of death and serious illness, must be recognised as an urgent global health issue together with HIV, malaria and TB, say the UK All-Party Parliamentary Group (APPG) on Pneumococcal Disease Prevention in the Developing World in a report launching at the House of Lords today. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||